• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYBoard
  • MYInsights
  • Strategy & Consulting
  • Contact Us
Select Page

Optimizing Oncology Clinical Pathways at the Point of Care

by MM360 Staff | Apr 17, 2025 | Uncategorized

Source: ASCO Daily News Dr. John Sweetenham, Dr. Larry Shulman, and Dr. Rebecca Maniago discuss the integration of clinical pathways and decision support tools into the cancer center workflow, challenges to implementation at the point of care, and the promise of AI to...

FDA sBLA Submitted for Anktiva Plus BCG in Papillary Bladder Cancer

by MM360 Staff | Apr 16, 2025 | Uncategorized

Source: CureToday articles A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC. Read More

Breaking Down The Use of Rina-S in Advanced Ovarian Cancer

by MM360 Staff | Apr 16, 2025 | Uncategorized

Source: CureToday articles Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer. Read More

TLX101 Demonstrated Efficacy in Recurrent High-Grade Glioma

by MM360 Staff | Apr 16, 2025 | Uncategorized

Source: CureToday articles TLX101 therapy was efficacious in recurrent high-grade glioma, a type of brain cancer, according to preliminary results from the phase 2 IPAX-Linz study. Read More

15% of U.S. Cancer Patients Are Active Smokers at Time of Diagnosis

by MM360 Staff | Apr 16, 2025 | Uncategorized

Source: CureToday articles The addition of smoking status to the National Cancer Database might inform more effective treatment for smokers with cancer. Read More

Lung cancer screening can’t leave anyone in the UK behind

by MM360 Staff | Apr 16, 2025 | Uncategorized

Source: Cancer Research UK – Cancer News The post Lung cancer screening can’t leave anyone in the UK behind appeared first on Cancer Research UK – Cancer News. Read More
« Older Entries
Next Entries »

Recent Content

  • Risk of lymphoid malignancy associated with cancer predisposition genes
  • Large-scale human myeloma cell line small molecule compound screen dataset
  • Optimal Jakafi Dosing Associated With Improved Outcomes in Myelofibrosis
  • PCV10 Elicits Durable Immune Response in T2D, Though Response Remains Inferior to Non-Diabetics
  • AAN 2025: Insights on Pediatric Multiple Sclerosis Treatment and Management
  • Illuminating Compassion in Cancer Care
  • Renowned Breast Cancer Physician-Scientist Dr. Hope S. Rugo to Lead City of Hope’s Women’s Cancers Program
  • Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
  • Reassessing Immunotherapy Use in Advanced Renal Cell Carcinoma
  • SPPCP 2025: Highlights and Can’t-Miss Sessions From the Virtual Conference on Pain and Palliative Care Pharmacy
  • Facebook
  • X
  • Instagram
©2016-2024 MYELOMA360
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT